2026. AI-DRIVEN MICROBIOME-BASED BIOMARKERS FOR EARLY DIAGNOSIS OF CANCER AND AUTOIMMUNE DISEASES: CURRENT ADVANCES AND FUTURE PERSPECTIVES. Review Journal of Neurological & Medical Sciences Review. 4, 3 (Jul. 2026), 822–832. DOI:https://doi.org/10.63075/s7xxds32.